Zicam Maker Matrixx Settles With Shareholders Over H.I.G. Buyout
This article was originally published in The Tan Sheet
Executive Summary
Matrixx Initiatives remains mired in multiple lawsuits despite settling litigation with shareholders over the firm’s handling of its 2010 buyout.
You may also be interested in...
Zicam Marketer Matrixx Tabs Another Pharma Consumer Health Veteran As CEO
Private equity firm Gryphon Investments appoints Marc Rovner, with executive experience at Pfizer, Reckitt, Unilever and BI, to helm the Zicam brand homeopathic cold remedy marketer in a shakeup that also puts consumer health care industry veterans at lead posts for sales, marketing and strategy.
Zicam Marketer Matrixx Tabs Another Pharma Consumer Health Veteran As CEO
Private equity firm Gryphon Investments appoints Marc Rovner, with executive experience at Pfizer, Reckitt, Unilever and BI, to helm the Zicam brand homeopathic cold remedy marketer in a shakeup that also puts consumer health care industry veterans at lead posts for sales, marketing and strategy.
Matrixx Appoints Scerene Healthcare Executive To Lead Turnaround
M’lou Arnett talks about how her experience, including designing the “Mr. Mucus” advertising icon for the Mucinex cough treatment line, has prepared her for the challenge of growing Matrixx’s revenues in the wake of removing the Zicam gel and swab products from the market.